Amgen Inc.
Thousand Oaks, CA Amgen Inc.
- UEI
- D92HARF1LKA9
- CAGE
- 0JVZ6
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Amgen Inc.
D92HARF1LKA9
- Amgen USA Inc. XPGNQMXHP493
- Onyx Pharmaceuticals, Inc. LTNJZJNJJGQ1
-
Amgen Inc.
D92HARF1LKA9
- SAM.gov registration date
- Physical address
- 1 Amgen Center Dr, Thousand Oaks, CA 91320, USA
- Website
- amgen.com
- Founded
- 1980
- Employees
- 10K-50K
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Nplate administration kit development for the treatment of approved indications, including acute radiation syndrome… | Office of the Assistant Secretary for Preparedness and Response | $7,290,924 | |
| This contract is to advance the development of romiplostim for treatment of hematopoietic subsyndrome-acute radiation… | Office of the Assistant Secretary for Preparedness and Response | $26,408,674 | |
| Drugs | Veterans Integrated Service Network 22 | $186,366 | |
| Exjade | Veterans Integrated Service Network 8 | $6,880 | |
| Medicine required for clinical trial 551 for the CSP | Veterans Integrated Service Network 22 | $1,050,168 |
About Amgen Inc.
Amgen Inc. is a prominent biopharmaceutical company that has been registered to receive awards from the U.S. federal government since May 7, 2001. As a for-profit organization and manufacturer of goods, Amgen primarily provides pharmaceutical products and services to various government agencies. The company has secured federal contract awards for the development of medical countermeasures, including vaccines and therapeutics, as well as the supply of influenza vaccines. Amgen's expertise in biotechnology and its focus on developing innovative medicines for serious illnesses have positioned it as a valuable partner for government agencies seeking advanced medical solutions.
Recent federal contract awards to Amgen Inc. and its subsidiaries demonstrate the company's involvement in critical health-related projects. A significant contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) tasked Amgen with developing an NPLATE administration kit for the treatment of approved indications, including Acute Radiation Syndrome (ARS). This cost-sharing contract, valued at $7,290,923.50, extends through August 2026. Additionally, Amgen USA Inc., a subsidiary, has been contracted to supply influenza vaccines to various government entities. The Department of Veterans Affairs awarded a $74,669.20 contract for AFLURIA QUADRIVALENT pre-filled syringes, while the Department of Justice Bureau of Prisons engaged Amgen to provide flu shots for staff at the Federal Correctional Institution Terminal Island in California through multiple delivery orders. These contracts highlight Amgen's role in supporting public health initiatives and government vaccination programs across different sectors, including veterans' health and correctional facilities. No set-aside designations were identified in these recent awards, indicating that Amgen competes for these contracts in the open market.
Quick answers
What is Amgen Inc.'s UEI?
Amgen Inc.'s Unique Entity ID (UEI) in SAM.gov is D92HARF1LKA9.
What is Amgen Inc.'s CAGE code?
Amgen Inc.'s CAGE code is 0JVZ6.
What is Amgen Inc.'s primary NAICS code?
Amgen Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Amgen Inc. located?
Amgen Inc.'s physical address in SAM.gov is 1 Amgen Center Dr, Thousand Oaks, CA 91320, USA.
Is Amgen Inc. registered in SAM.gov?
Yes. Amgen Inc.'s SAM.gov registration is active through March 19, 2027.
What is Amgen Inc.'s most recent federal award?
Amgen Inc.'s most recent federal contract award is Nplate administration kit development for the treatment of approved indications, including acute radiation syndrome… (75A50123C00040), from Office of the Assistant Secretary for Preparedness and Response, on August 28, 2023.
On GovTribe
See Amgen Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors